422 related articles for article (PubMed ID: 16324768)
21. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors.
Tsurutani J; Fukuoka J; Tsurutani H; Shih JH; Hewitt SM; Travis WD; Jen J; Dennis PA
J Clin Oncol; 2006 Jan; 24(2):306-14. PubMed ID: 16330671
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of PTEN and PI3K/AKT signal transduction pathway in non-small cell lung cancer.
Yun F; Jia Y; Li X; Yuan L; Sun Q; Yu H; Shi L; Yuan H
Int J Clin Exp Pathol; 2013; 6(10):2112-20. PubMed ID: 24133589
[TBL] [Abstract][Full Text] [Related]
24. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
[TBL] [Abstract][Full Text] [Related]
25. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between PTEN expression and PI3K/AKT signal pathway in colon carcinoma].
Qi JK; Huang XL; Meng ZM; Gan HT; Fu DG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):644-6, 654. PubMed ID: 19764563
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Shen WM; Yin JN; Xu RJ; Xu DF; Zheng SY
Kaohsiung J Med Sci; 2019 Jul; 35(7):401-407. PubMed ID: 31001918
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma.
Tsurutani J; Steinberg SM; Ballas M; Robertson M; LoPiccolo J; Soda H; Kohno S; Egilsson V; Dennis PA
Lung Cancer; 2007 Jan; 55(1):115-21. PubMed ID: 17097759
[TBL] [Abstract][Full Text] [Related]
30. Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer.
Terakawa N; Kanamori Y; Yoshida S
Endocr Relat Cancer; 2003 Jun; 10(2):203-8. PubMed ID: 12790783
[TBL] [Abstract][Full Text] [Related]
31. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
[TBL] [Abstract][Full Text] [Related]
32. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
[TBL] [Abstract][Full Text] [Related]
33. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
34. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
[TBL] [Abstract][Full Text] [Related]
35. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
[TBL] [Abstract][Full Text] [Related]
36. PTEN and PI3K/AKT in non-small-cell lung cancer.
Pérez-Ramírez C; Cañadas-Garre M; Molina MÁ; Faus-Dáder MJ; Calleja-Hernández MÁ
Pharmacogenomics; 2015 Nov; 16(16):1843-62. PubMed ID: 26555006
[TBL] [Abstract][Full Text] [Related]
37. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H
Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
40. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
